The synthetic killer peptide KP impairs Candida albicans biofilm in vitro

Abstract

Candida albicans is a commensal organism, commonly inhabiting mucosal surfaces of healthy individuals, as a part of the resident microbiota. However, in susceptible hosts, especially hospitalized and/or immunocompromised patients, it may cause a wide range of infections. The presence of abiotic substrates, such as central venous or urinary catheters, provides an additional niche for Candida attachment and persistence, particularly via biofilm development. Furthermore, Candida biofilm is poorly susceptible to most antifungals, including azoles. Here we investigated the effects of a synthetic killer peptide (KP), known to be active in vitro, ex vivo and/or in vivo against different pathogens, on C. albicans biofilm. Together with a scrambled peptide used as a negative control, KP was tested against Candida biofilm at different stages of development. A reference strain, two fluconazole-resistant and two fluconazole-susceptible C. albicans clinical isolates were used. KP-induced C. albicans oxidative stress response and membrane permeability were also analysed. Moreover, the effect of KP on transcriptional profiles of C. albicans genes involved in different stages of biofilm development, such as cell adhesion, hyphal development and extracellular matrix production, was evaluated. Our results clearly show that the treatment with KP strongly affected the capacity of C. albicans to form biofilm and significantly impairs preformed mature biofilm. KP treatment resulted in an increase in C. albicans oxidative stress response and membrane permeability; also, biofilm-related genes expression was significantly reduced. Comparable inhibitory effects were observed in all the strains employed, irrespective of their resistance or susceptibility to fluconazole. Finally, KP-mediated inhibitory effects were observed also against a catheter-associated C. albicans biofilm. This study provides the first evidence on the KP effectiveness against C. albicans biofilm, suggesting that KP may be considered as a potential novel tool for treatment and prevention of biofilm-related C. albicans infections.

Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro

“…In line with other bioluminescence analysis systems [ 28 , 31 , 46 ], here we show that quantification of bioluminescence by RLU provides data in line with those obtained by conventional techniques for biofilm quantification. When compared to techniques such as CFU and CV determination, our method requires shorter processing times and it provides more accurate data for discriminating kinetic differences among different experimental groups.…”

“…Every 24 h, the medium was replaced with fresh medium with or without gentamicin (4 μg/ml). After 24, 48 or 72 h of incubation, coverslips were washed twice with PBS at RT, air-dried, transferred to a microscope slide and analyzed, as previously described [ 31 ], with a Nikon Eclipse 90i imaging system equipped with Nomarski DIC optics (Nikon Instruments Inc. USA) (40X). Images were acquired by a DS-2Mv Nikon digital camera and analysed using the Nikon NISELEMENTS version D3.1 software.…”

Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against <i>Staphylococcus aureus</i>, <i>Pseudomonas aeruginosa</i> and <i>Candida albicans </i>

“…By a previously established model 41) , here we provide initial evidence on the efficacy of Cupral against preformed microbial biofilms. A marked inhibitory effect has been observed with respect to each of the three microorganisms tested, as shown by the significant and dose-dependent reduction of microbial biomass.…”

Pulsed Laser Deposited Biocompatible Lithium-Doped Hydroxyapatite Coatings with Antimicrobial Activity

“…Following adherence to abiotic substrates (i.e., catheters and other medical devices), C. albicans develops into a three-dimensional community containing round-budding yeast cells, oval pseudo-hyphal cells and elongated hyphal cells embedded in an extracellular polysaccharides' matrix [39]. C. albicans biofilm development follows a sequential dynamic over a 24-48 h period, starting with initial adhesion of single fungal yeast cells, continuing with a cellular proliferation and colonization of the surface and the switching to filamentous hyphal forms, a hallmark of the initiation of biofilm formation, followed by maturation, through the accumulation of the protecting extracellular polysaccharide matrix.…”